XML 88 R18.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Other Assets | 12 Months Ended
--- | ---
Dec. 31, 2013
Other Assets. |
Other Assets | (10) Other Assets The Company's other assets consisted of the following (in thousands):
|  | December 31, |
--- | --- | --- | ---
|  | 2013 |  | 2012 |
Straight-line rent assets, net of allowance of $34,230 and $33,521, respectively |  | $ | 368,919 |  | $ | 306,294 |
Marketable debt securities(1) |  |  | 244,089 |  |  | 222,809 |
Leasing costs, net |  |  | 104,601 |  |  | 93,763 |
Deferred financing costs, net |  |  | 42,106 |  |  | 45,490 |
Goodwill |  |  | 50,346 |  |  | 50,346 |
Marketable equity securities |  |  | — |  |  | 24,829 |
Other(2) |  |  | 57,644 |  |  | 44,989 |
Total other assets |  | $ | 867,705 |  | $ | 788,520 |
(1) Includes £137.0 million of Four Seasons senior unsecured notes translated into U.S. dollars (see below for additional information). (2) Includes a $5.4 million allowance for losses related to accrued interest receivable on the Delphis loan. At both December 31, 2013 and 2012, the net carrying value of interest accrued related to the Delphis loan was zero. See Note 7 for additional information about the Delphis loan and the related impairment. At both December 31, 2013 and 2012, includes a loan receivable of $10 million from HCP Ventures IV, LLC, an unconsolidated joint venture (see Note 8 for additional information) with an interest rate of 12% which matures in May 2014. The loan is secured by the Company's joint venture partner's 80% partnership interest in the joint venture. In June 2011, the Company purchased approximately $22 million of marketable equity securities that were classified as available-for-sale. At December 31, 2011, the Company incurred a $5 million impairment for these securities as it concluded the decrease in value of such securities below their carrying value was other-than-temporary. At December 31, 2012, the fair value and adjusted cost basis of the marketable equity securities were $25 million and $17 million, respectively. During the year ended December 31, 2013, the Company realized gains from the sale of marketable equity securities of $11 million, which were included in other income, net. Four Seasons Health Care Senior Unsecured Notes On June 28, 2012, the Company purchased senior unsecured notes with an aggregate par value of £138.5 million at a discount for £136.8 million ($214.9 million). The notes were issued by Elli Investments Limited, a subsidiary of Terra Firma, a European private equity firm, as part of its financing for the acquisition of Four Seasons Health Care ("Four Seasons"), an elderly and specialist care provider in the United Kingdom. The notes mature in June 2020 and are non-callable through June 2016. The notes bear interest on their par value at a fixed rate of 12.25% per annum, with an original issue discount resulting in a yield to maturity of 12.5%. This investment was financed by a GBP denominated unsecured term loan that is discussed in Note 11. These senior unsecured notes are accounted for as marketable debt securities and classified as held-to-maturity.

X
- Details
Name: | us-gaap_OtherAssetsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_OtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration